Agency Information Collection Activities: Proposed Collection; Comment Request, 18388 [E9-9187]
Download as PDF
<![CDATA[
18388
Federal Register / Vol. 74, No. 76 / Wednesday, April 22, 2009 / Notices
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 7–1044, One Choke Cherry Road,
Rockville, MD 20857 and e-mail her a
copy at summer.king@samhsa.hhs.gov.
Written comments should be received
within 60 days of this notice.
Dated: April 13, 2009.
Elaine Parry,
Director, Office of Program Services.
[FR Doc. E9–9193 Filed 4–21–09; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Mandatory
Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930–
0158)—Extension
SAMHSA’s Mandatory Guidelines for
Federal Workplace Drug Testing
Programs will request OMB approval for
the Federal Drug Testing Custody and
Control Form for Federal agency and
federally regulated drug testing
programs which must comply with the
HHS Mandatory Guidelines for Federal
Workplace Drug Testing Programs (69
FR 19644) dated April 13, 2004, and for
the information provided by laboratories
for the National Laboratory Certification
Program (NLCP).
The Federal Drug Testing Custody
and Control Form is used by all Federal
agencies and employers regulated by the
Department of Transportation to
document the collection and chain of
custody of urine specimens at the
collection site, for laboratories to report
results, and for Medical Review Officers
to make a determination. The Federal
Drug Testing Custody and Control Form
approved by OMB three years ago is
being resubmitted for OMB approval
without any revision.
Prior to an inspection, a laboratory is
required to submit specific information
regarding its laboratory procedures.
Collecting this information prior to an
inspection allows the inspectors to
thoroughly review and understand the
laboratory’s testing procedures before
arriving at the laboratory.
The NLCP application form has not
been revised compared to the previous
form.
The annual total burden estimates for
the Federal Drug Testing Custody and
Control Form, the NLCP application, the
NLCP inspection checklist, and NLCP
recordkeeping requirements are shown
in the following table.
Burden/
response
(hrs.)
Form/respondent
Number of
responses
Total annual
burden
(hrs.)
Custody and Control Form:
Donor ....................................................................................................................................
Collector ................................................................................................................................
Laboratory .............................................................................................................................
Medical Review Officer .........................................................................................................
Laboratory Application .................................................................................................................
Laboratory Inspection Checklist ..................................................................................................
Laboratory Recordkeeping ..........................................................................................................
.08
.07
.05
.05
3.00
3.00
250.00
7,096,000
7,096,000
7,096,000
7,096,000
3
100
50
567,680
496,720
354,800
354,800
9
300
12,500
Total ......................................................................................................................................
........................
........................
1,786,809
dwashington3 on PROD1PC60 with NOTICES
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 7–1044, One Choke Cherry Road,
Rockville, MD 20857 and e-mail her a
copy at summer.king@samhsa.hhs.gov.
Written comments should be received
within 60 days of this notice.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: April 13, 2009.
Elaine Parry,
Director, Office of Program Services.
[FR Doc. E9–9187 Filed 4–21–09; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
BILLING CODE 4162–20–P
VerDate Nov<24>2008
15:31 Apr 21, 2009
Jkt 217001
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Nutrition and
Aging of Brain.
Date: June 9, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
National Institutes of Health, Gateway
Building, Room 2C/212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 74, Number 76 (Wednesday, April 22, 2009)]
[Notices]
[Page 18388]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9187]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Mandatory Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930-0158)--Extension
SAMHSA's Mandatory Guidelines for Federal Workplace Drug Testing
Programs will request OMB approval for the Federal Drug Testing Custody
and Control Form for Federal agency and federally regulated drug
testing programs which must comply with the HHS Mandatory Guidelines
for Federal Workplace Drug Testing Programs (69 FR 19644) dated April
13, 2004, and for the information provided by laboratories for the
National Laboratory Certification Program (NLCP).
The Federal Drug Testing Custody and Control Form is used by all
Federal agencies and employers regulated by the Department of
Transportation to document the collection and chain of custody of urine
specimens at the collection site, for laboratories to report results,
and for Medical Review Officers to make a determination. The Federal
Drug Testing Custody and Control Form approved by OMB three years ago
is being resubmitted for OMB approval without any revision.
Prior to an inspection, a laboratory is required to submit specific
information regarding its laboratory procedures. Collecting this
information prior to an inspection allows the inspectors to thoroughly
review and understand the laboratory's testing procedures before
arriving at the laboratory.
The NLCP application form has not been revised compared to the
previous form.
The annual total burden estimates for the Federal Drug Testing
Custody and Control Form, the NLCP application, the NLCP inspection
checklist, and NLCP recordkeeping requirements are shown in the
following table.
----------------------------------------------------------------------------------------------------------------
Burden/
Form/respondent response Number of Total annual
(hrs.) responses burden (hrs.)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form:
Donor....................................................... .08 7,096,000 567,680
Collector................................................... .07 7,096,000 496,720
Laboratory.................................................. .05 7,096,000 354,800
Medical Review Officer...................................... .05 7,096,000 354,800
Laboratory Application.......................................... 3.00 3 9
Laboratory Inspection Checklist................................. 3.00 100 300
Laboratory Recordkeeping........................................ 250.00 50 12,500
-----------------------------------------------
Total....................................................... .............. .............. 1,786,809
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 7-1044, One Choke Cherry Road, Rockville, MD 20857 and e-mail her
a copy at summer.king@samhsa.hhs.gov. Written comments should be
received within 60 days of this notice.
Dated: April 13, 2009.
Elaine Parry,
Director, Office of Program Services.
[FR Doc. E9-9187 Filed 4-21-09; 8:45 am]
BILLING CODE 4162-20-P
